Comparative Analysis of Targeted Next-Generation Sequencing Panels for the Detection of Gene Mutations in Chronic Lymphocytic Leukemia: An ERIC Multi-Center Study

Haematologica - Italy
doi 10.3324/haematol.2019.234716
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

TP53 Gene Mutation Analysis in Chronic Lymphocytic Leukemia by Nanopore MinION Sequencing

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2016English

Application of Multi-Objective Optimization to Pooled Experiments of Next Generation Sequencing for Detection of Rare Mutations

PLoS ONE
Multidisciplinary
2014English

Determination of CEBPA Mutations by Next Generation Sequencing in Pediatric Acute Leukemia

Bratislava Medical Journal
2018English

Diagnosis of Mosaic Mutations in the MEN1 Gene by Next Generation Sequencing.

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

Improving the Detection of Patients With Inherited Predispositions to Hematologic Malignancies Using Next-Generation Sequencing-Based Leukemia Prognostication Panels

Cancer
Cancer ResearchOncology
2018English

Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2017English

Next Generation Sequencing in Synovial Sarcoma Reveals Novel Gene Mutations

Oncotarget
Oncology
2015English

New Mutations in Chronic Lymphocytic Leukemia Identified by Target Enrichment and Deep Sequencing

PLoS ONE
Multidisciplinary
2012English

Erratum To: Gene Panels and Primers for Next Generation Sequencing Studies on Neurodegenerative Disorders

Molecular and Cellular Toxicology
PharmacologyMutagenesisPublic HealthEnvironmentalHealthForensic MedicineToxicologyPathologyPharmaceuticsOccupational Health
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy